LIVERFASt™ has now been granted CPT Code.
LIVERFASt™, a non-invasive diagnostic tool for diagnosis, screening and monitoring patient with liver diseases.
Patent Technology
CPT Code: 0166U
FDA – De Novo 510K
Artifical Technology based Platform
Non-invasive disease detection means earlier diagnosis and earlier intervention for better patient outcomes.
Risk stratification among large patient populations allows for better management leading to cost reductions.
Regular surveillance with easily repeatable non-invasive diagnostics enables optimized disease management.
Fibronostics Appoints Dr. Stephen A. Harrison to its Board of Advisors
Learn more
